StartUp Health raises 31 million dollars from the Chiesi Group and a prominent group of other large pharmaceuticals companies and healthcare organizations

StartUp Health announced a successful fundraise of 31 million dollars for its Transformer Fund II from a prominent consortium of strategic partners, including, as previously announced in June, the Chiesi Group. Other partners in this fund include large healthcare organizations, multinational large pharma and several prominent healthcare and technology investors.

“StartUp Health has an unprecedented understanding of the impact that health innovation has on the entire industry, and on people around the world” said Giacomo Chiesi, Head of Global Corporate Development of Chiesi Group. “The entrepreneurs in StartUp Health’s portfolio, combined with our vision for the future of health and deep expertise in respiratory care, neonatology, special care and rare diseases, will significantly change the way we treat and care for patients”.

This funding round, “StartUp Health Transformer Fund II”, will target bringing in an additional 200 portfolio companies committed to 10 “health moonshots”, aimed at addressing significant unmet medical needs with a view to revolutionizing healthcare.

“Digital technologies offer unlimited possibilities, more than what we manage to exploit or imagine today” said Umberto Stefani, Group Information and Communication Technology Director of Chiesi Group. “Real time data are going to improve the way we treat patients and the amount of available data will ensure a significant progress to the development of new treatments. Collaboration is the key to accelerate this process”.

StartUp Health currently boasts the largest digital health portfolio in the world, with over 250 digital healthcare organizations in six continents and 21 countries and with a global network of over 200.000 investors, customers and partners.